JP2005513096A5 - - Google Patents

Download PDF

Info

Publication number
JP2005513096A5
JP2005513096A5 JP2003554163A JP2003554163A JP2005513096A5 JP 2005513096 A5 JP2005513096 A5 JP 2005513096A5 JP 2003554163 A JP2003554163 A JP 2003554163A JP 2003554163 A JP2003554163 A JP 2003554163A JP 2005513096 A5 JP2005513096 A5 JP 2005513096A5
Authority
JP
Japan
Prior art keywords
cyclosporine
solvent
surfactant
derivative
lipophilic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003554163A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005513096A (ja
Filing date
Publication date
Priority claimed from NZ51626901A external-priority patent/NZ516269A/en
Priority claimed from NZ51983702A external-priority patent/NZ519837A/en
Application filed filed Critical
Priority claimed from PCT/CA2002/001968 external-priority patent/WO2003053404A1/en
Publication of JP2005513096A publication Critical patent/JP2005513096A/ja
Publication of JP2005513096A5 publication Critical patent/JP2005513096A5/ja
Pending legal-status Critical Current

Links

JP2003554163A 2001-12-20 2002-12-19 シクロスポリン、親水性界面活性剤及び親油性界面活性剤を含んで成る医薬組成物 Pending JP2005513096A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ51626901A NZ516269A (en) 2001-12-20 2001-12-20 Pharmaceutical compositions comprising cyclosporine
NZ51983702A NZ519837A (en) 2002-06-28 2002-06-28 Pharmaceutical compositions comprising a cyclosporin or cyclosporin derivative
PCT/CA2002/001968 WO2003053404A1 (en) 2001-12-20 2002-12-19 Pharmaceutical compositions comprising a cyclosporin, a hydrophilic surfactant and a lipophilic surfactant

Publications (2)

Publication Number Publication Date
JP2005513096A JP2005513096A (ja) 2005-05-12
JP2005513096A5 true JP2005513096A5 (https=) 2006-02-09

Family

ID=26652297

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003554163A Pending JP2005513096A (ja) 2001-12-20 2002-12-19 シクロスポリン、親水性界面活性剤及び親油性界面活性剤を含んで成る医薬組成物

Country Status (6)

Country Link
US (2) US20050129718A1 (https=)
EP (1) EP1455753A1 (https=)
JP (1) JP2005513096A (https=)
BR (1) BR0215187A (https=)
CA (1) CA2471241A1 (https=)
WO (1) WO2003053404A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2604943C (en) 2005-04-15 2013-09-17 Clarus Therapeutics, Inc. Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
US8492369B2 (en) 2010-04-12 2013-07-23 Clarus Therapeutics Inc Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
US20070015691A1 (en) 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US20070015693A1 (en) * 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US7288520B2 (en) * 2005-07-13 2007-10-30 Allergan, Inc. Cyclosporin compositions
US7297679B2 (en) * 2005-07-13 2007-11-20 Allergan, Inc. Cyclosporin compositions
US7276476B2 (en) * 2005-07-13 2007-10-02 Allergan, Inc. Cyclosporin compositions
US7202209B2 (en) 2005-07-13 2007-04-10 Allergan, Inc. Cyclosporin compositions
US7501393B2 (en) 2005-07-27 2009-03-10 Allergan, Inc. Pharmaceutical compositions comprising cyclosporins
US7745400B2 (en) * 2005-10-14 2010-06-29 Gregg Feinerman Prevention and treatment of ocular side effects with a cyclosporin
US9839667B2 (en) 2005-10-14 2017-12-12 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
CA2642656A1 (en) * 2006-02-22 2007-09-07 Novartis Pharma Ag System for delivering nebulized cyclosporine and methods of treatment
EP2079456B1 (en) 2007-04-04 2012-12-05 Sigmoid Pharma Limited Pharmaceutical cyclosporin compositions
ES2649112T3 (es) 2009-05-18 2018-01-10 Sigmoid Pharma Limited Composición que comprende gotas de aceite
CN107582526A (zh) 2009-08-12 2018-01-16 希格默伊德药业有限公司 包含聚合物基质和油相的免疫调节组合物
JP5283654B2 (ja) * 2010-03-30 2013-09-04 中日本カプセル 株式会社 ソフトカプセル用の充填組成物
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
WO2012159960A1 (en) * 2011-05-20 2012-11-29 Aventis Pharmaceuticals Inc. Pharmaceutical composition comprising fexofenadine
GB201304662D0 (en) 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
US10245273B2 (en) 2013-12-26 2019-04-02 Clarus Therapeutics, Inc. Oral pharmaceutical products and methods of use combining testosterone esters with hypolipidemic agents
EP3881829A1 (en) 2014-11-07 2021-09-22 Sublimity Therapeutics Limited Compositions comprising cyclosporin
WO2020123551A1 (en) * 2018-12-10 2020-06-18 Halo Science LLC Stable formulations of anesthetics and associated dosage forms
US11564933B2 (en) 2019-04-12 2023-01-31 Tolmar, Inc. Methods of treating testosterone deficiency

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI65914C (fi) * 1978-03-07 1984-08-10 Sandoz Ag Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
NZ247516A (en) * 1993-04-28 1995-02-24 Bernard Charles Sherman Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5858401A (en) * 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
US5798333A (en) * 1996-09-17 1998-08-25 Sherman; Bernard C. Water-soluble concentrates containing cyclosporins
WO1998040094A1 (en) * 1997-03-12 1998-09-17 Abbott Laboratories Hydrophilic binary systems for the administration of cyclosporine
CA2285983A1 (en) * 1997-04-29 1998-11-05 Bernard Charles Sherman Emulsion preconcentrate comprising a cyclosporin and acetylated monoglyceride
NZ314702A (en) * 1997-04-29 1998-07-28 Bernard Charles Sherman Pharmaceutical composition comprising a cyclosporin in a solvent system of acetylated monoglycerides and a surfactant and optionally a hydrophilic solvent
IN188719B (https=) * 1997-09-08 2002-11-02 Panacea Biotec Ltd
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
US6187747B1 (en) * 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
CN1236813C (zh) * 1998-12-11 2006-01-18 药品处理公司 水难溶性药物的自乳化组合物
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6057289A (en) * 1999-04-30 2000-05-02 Pharmasolutions, Inc. Pharmaceutical composition comprising cyclosporin in association with a carrier in a self-emulsifying drug delivery system
GB9912476D0 (en) * 1999-05-28 1999-07-28 Novartis Ag Organic compounds
GB2362573A (en) * 2000-05-25 2001-11-28 Cipla Ltd Cyclosporin formulation

Similar Documents

Publication Publication Date Title
JP2005513096A5 (https=)
JP2005524658A5 (https=)
JP2002525313A5 (https=)
JP2001525363A5 (https=)
JP2006528990A5 (https=)
CA2412885A1 (en) Porous celecoxib matrices and methods of manufacture thereof
CA2476496A1 (en) Controlled release dosage forms
JP2008523153A5 (https=)
NO20051688L (no) Farmasoytiske blandinger som har en modifisert baerer
JP2005500363A5 (https=)
IT9020054A1 (https=)
JP3884457B2 (ja) オーラルケア用カプセル
JP2003506416A5 (https=)
JP2008521926A (ja) 局所用ネパフェナク処方物
FI3250182T3 (fi) Dispergoituvia koostumuksia
JP2009527505A5 (https=)
JP2002532535A5 (https=)
BR0215187A (pt) Composições farmacêuticas que compreendem uma ciclosporina, um tensoativo hidrofìlico e um tensoativo lipofìlico
CN120091810A (zh) 用于治疗病毒性疾病的方法和生物利用度高渗透性化合物
FI941046A0 (fi) Farmaseuttinen menetelmä
JP2004534739A5 (https=)
CN1499959A (zh) 含有水溶性差的活性成分、表面活性剂和水溶性聚合物的药物组合物
JP2008538751A5 (https=)
TW550087B (en) Solubilized sertraline compositions
JP2005187328A (ja) イブプロフェン含有解熱鎮痛組成物、及び感冒薬